Rheumatology

2021

1. 2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice

   Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 707-713

2. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

   Annals of the Rheumatic Diseases, Vol. 80, Núm. 10, pp. 1278-1285

3. A Complex Proteomic Response of the Parasitic Nematode Anisakis simplex s.s. to Escherichia coliLipopolysaccharide

   Molecular & cellular proteomics : MCP, Vol. 20, pp. 100166

4. A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

   Osteoarthritis and Cartilage, Vol. 29, Núm. 8, pp. 1147-1154

5. A family-based study to identify genetic biomarkers of fibromyalgia: consideration of patients' subgroups

   Clinical and experimental rheumatology, Vol. 39, Núm. 3, pp. 144-152

6. Abatacept in monotherapy vs combined in interstitial lung disease of rheumatoid arthritis-multicentre study of 263 Caucasian patients

   Rheumatology (Oxford, England), Vol. 61, Núm. 1, pp. 299-308

7. Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: A systematic review

   Immunotherapy, Vol. 13, Núm. 5, pp. 433-458

8. Adherence to treatment in patients with rheumatoid arthritis from spain

   Patient Preference and Adherence, Vol. 15, pp. 111-117

9. An update on the role of leptin in the immuno-metabolism of cartilage

   International Journal of Molecular Sciences, Vol. 22, Núm. 5, pp. 1-16

10. Apolipoprotein C3 and beta-cell dysfunction are linked in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology

11. Arteritis de las células gigantes. Recomendaciones en Atención Primaria

    Semergen: revista española de medicina de familia, Núm. 4, pp. 256-266

12. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: Results from the REUMAVID study (phase 1)

    RMD Open, Vol. 7, Núm. 1

13. Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19

    JAMA Network Open

14. Association of accelerated dynamics of telomere sequence loss in peripheral blood leukocytes with incident knee osteoarthritis in Osteoarthritis Initiative cohort

    Scientific Reports, Vol. 11, Núm. 1

15. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1137-1146

16. Atypical presentation of immunoglobulin G4-related disease as subglottic stenosis: a case-based review

    Rheumatology International, Vol. 41, Núm. 6, pp. 1161-1167

17. Autophagy Activation by Resveratrol Reduces Severity of Experimental Rheumatoid Arthritis

    Molecular Nutrition and Food Research, Vol. 65, Núm. 2

18. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis

    Scientific Reports, Vol. 11, Núm. 1

19. Baseline clinical characteristics of predicted structural and pain progressors in the IMI-APPROACH knee OA cohort

    RMD Open, Vol. 7, Núm. 3

20. Body mass index and disease activity in chronic inflammatory rheumatic diseases: Results of the cardiovascular in rheumatology (CARMA) project

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-10